These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

816 related articles for article (PubMed ID: 33653340)

  • 1. Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma.
    Bian T; Zheng M; Jiang D; Liu J; Sun H; Li X; Liu L; Zhang J; Liu Y
    Cancer Cell Int; 2021 Mar; 21(1):144. PubMed ID: 33653340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer/testis antigen HEMGN correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.
    Jiang Y; Yu L; Hu Q; Kang Y; You J; Huang C; Xu X; Chen L
    Mol Immunol; 2023 Jan; 153():226-237. PubMed ID: 36563642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
    Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
    Front Immunol; 2021; 12():724741. PubMed ID: 34335635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
    Wang W; Ren S; Wang Z; Zhang C; Huang J
    Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TUBA1C is a Prognostic Marker in Low-grade Glioma and Correlates with Immune Cell Infiltration in the Tumor Microenvironment.
    Zhu H; Hu X; Gu L; Jian Z; Li L; Hu S; Qiu S; Xiong X
    Front Genet; 2021; 12():759953. PubMed ID: 34721547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics analysis of BTK expression in lung adenocarcinoma: implications for immune infiltration, prognostic biomarkers, and therapeutic targeting.
    Jiao L; Tao Y; Ding H; Wu F; Liu Y; Li C; Li F
    3 Biotech; 2024 Sep; 14(9):215. PubMed ID: 39220827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation.
    Li Z; Hu M; Qiu J; Feng J; Zhang R; Wu H; Hu G; Ren J
    Med Sci Monit; 2022 Jan; 28():e933447. PubMed ID: 35027526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma.
    Zheng M; Liu J; Bian T; Liu L; Sun H; Zhou H; Zhao C; Yang Z; Shi J; Liu Y
    Int Immunopharmacol; 2021 Jan; 90():107134. PubMed ID: 33168407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures.
    Huo C; Zhang MY; Li R; Liu TT; Li JP; Qu YQ
    Front Cell Dev Biol; 2021; 9():645482. PubMed ID: 34368114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analyzes identify CCT3 as a modulator to shape immunosuppressive tumor microenvironment in lung adenocarcinoma.
    Huang J; Hu B; Yang Y; Liu H; Fan X; Zhou J; Chen L
    BMC Cancer; 2023 Mar; 23(1):241. PubMed ID: 36918801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma.
    Wu YJ; Nai AT; He GC; Xiao F; Li ZM; Tang SY; Liu YP; Ai XH
    World J Surg Oncol; 2021 Sep; 19(1):274. PubMed ID: 34517904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatic prediction of miR-320a as a potential negative regulator of CDGSH iron-sulfur domain 2 (
    Zhao X; Li L; Li Y; Liu Y; Wang H; Tabrizi NS; Ye Z; Zhao Z
    Transl Cancer Res; 2024 Aug; 13(8):4485-4499. PubMed ID: 39262456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Expression of
    Chen Y; Zhou M; Gu X; Wang L; Wang C
    Dis Markers; 2022; 2022():8789515. PubMed ID: 35855850
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Wang Y; Wen H; Sun D
    Ann Transl Med; 2022 May; 10(9):519. PubMed ID: 35928739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPOCK2 Serves as a Potential Prognostic Marker and Correlates With Immune Infiltration in Lung Adenocarcinoma.
    Zhao J; Cheng M; Gai J; Zhang R; Du T; Li Q
    Front Genet; 2020; 11():588499. PubMed ID: 33244319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of JAK1 associated with immune infiltration and poor prognosis in lung adenocarcinoma.
    Cai J; Deng H; Luo L; You L; Liao H; Zheng Y
    Aging (Albany NY); 2020 Dec; 13(2):2073-2088. PubMed ID: 33323549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Expression of RTN1 in Lung Adenocarcinoma and 
Its Effect on Immune Microenvironment].
    Zhu S; Zu L; Xu S
    Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):385-395. PubMed ID: 35747917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates.
    Fan K; Zhang BH; Han D; Sun YC
    BMC Bioinformatics; 2023 Apr; 24(1):149. PubMed ID: 37069494
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Zhang XZ; Chen MJ; Fan PM; Jiang W; Liang SX
    Int J Gen Med; 2022; 15():2727-2745. PubMed ID: 35300128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.